C130H158N36O13S — CID 158630448
N-[1-(2-amino-2-oxoethyl)indazol-5-yl]-6-[cyclopropylmethyl(propyl)amino]pyrimidine-4-carboxamide;6-[cyclohexyl(cyclopropylmethyl)amino]-N-(4-methylsulfonylphenyl)pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[1-[2-(dimethylamino)-2-oxoethyl]indazol-5-yl]pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[2-[2-(dimethylamino)-2-oxoethyl]indazol-5-yl]pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-(1H-indol-4-yl)pyrimidine-4-carboxamide;2-[5-[[6-[cyclopropylmethyl(propyl)amino]pyrimidine-4-carbonyl]amino]indazol-1-yl]acetic acid (PubChem CID 158630448) has the molecular formula C130H158N36O13S and a molecular weight of 2465.00 g/mol. Its IUPAC name is N-[1-(2-amino-2-oxoethyl)indazol-5-yl]-6-[cyclopropylmethyl(propyl)amino]pyrimidine-4-carboxamide;6-[cyclohexyl(cyclopropylmethyl)amino]-N-(4-methylsulfonylphenyl)pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[1-[2-(dimethylamino)-2-oxoethyl]indazol-5-yl]pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[2-[2-(dimethylamino)-2-oxoethyl]indazol-5-yl]pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-(1H-indol-4-yl)pyrimidine-4-carboxamide;2-[5-[[6-[cyclopropylmethyl(propyl)amino]pyrimidine-4-carbonyl]amino]indazol-1-yl]acetic acid.
| Compound Name | N-[1-(2-amino-2-oxoethyl)indazol-5-yl]-6-[cyclopropylmethyl(propyl)amino]pyrimidine-4-carboxamide;6-[cyclohexyl(cyclopropylmethyl)amino]-N-(4-methylsulfonylphenyl)pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[1-[2-(dimethylamino)-2-oxoethyl]indazol-5-yl]pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[2-[2-(dimethylamino)-2-oxoethyl]indazol-5-yl]pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-(1H-indol-4-yl)pyrimidine-4-carboxamide;2-[5-[[6-[cyclopropylmethyl(propyl)amino]pyrimidine-4-carbonyl]amino]indazol-1-yl]acetic acid |
|---|---|
| PubChem CID | 158630448 |
| Molecular Formula | C130H158N36O13S |
| Molecular Weight | 2465.00 g/mol |
| Exact Mass | 2463.25 |
| IUPAC Name | N-[1-(2-amino-2-oxoethyl)indazol-5-yl]-6-[cyclopropylmethyl(propyl)amino]pyrimidine-4-carboxamide;6-[cyclohexyl(cyclopropylmethyl)amino]-N-(4-methylsulfonylphenyl)pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[1-[2-(dimethylamino)-2-oxoethyl]indazol-5-yl]pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[2-[2-(dimethylamino)-2-oxoethyl]indazol-5-yl]pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-(1H-indol-4-yl)pyrimidine-4-carboxamide;2-[5-[[6-[cyclopropylmethyl(propyl)amino]pyrimidine-4-carbonyl]amino]indazol-1-yl]acetic acid |
| SMILES | CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3c(cnn3CC(=O)N(C)C)c2)ncn1.CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3c(cnn3CC(=O)O)c2)ncn1.CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3c(cnn3CC(N)=O)c2)ncn1.CCCN(CC1CC1)c1cc(C(=O)Nc2ccc3nn(CC(=O)N(C)C)cc3c2)ncn1.CCCN(CC1CC1)c1cc(C(=O)Nc2cccc3[nH]ccc23)ncn1.CS(=O)(=O)c1ccc(NC(=O)c2cc(N(CC3CC3)C3CCCCC3)ncn2)cc1 |
| InChI | InChI=1S/2C23H29N7O2.C22H28N4O3S.C21H25N7O2.C21H24N6O3.C20H23N5O/c1-4-9-29(13-16-5-6-16)21-11-19(24-15-25-21)23(32)27-18-7-8-20-17(10-18)12-26-30(20)14-22(31)28(2)3;1-4-9-29(12-16-5-6-16)21-11-20(24-15-25-21)23(32)26-18-7-8-19-17(10-18)13-30(27-19)14-22(31)28(2)3;1-30(28,29)19-11-9-17(10-12-19)25-22(27)20-13-21(24-15-23-20)26(14-16-7-8-16)18-5-3-2-4-6-18;1-2-7-27(11-14-3-4-14)20-9-17(23-13-24-20)21(30)26-16-5-6-18-15(8-16)10-25-28(18)12-19(22)29;1-2-7-26(11-14-3-4-14)19-9-17(22-13-23-19)21(30)25-16-5-6-18-15(8-16)10-24-27(18)12-20(28)29;1-2-10-25(12-14-6-7-14)19-11-18(22-13-23-19)20(26)24-17-5-3-4-16-15(17)8-9-21-16/h7-8,10-12,15-16H,4-6,9,13-14H2,1-3H3,(H,27,32);7-8,10-11,13,15-16H,4-6,9,12,14H2,1-3H3,(H,26,32);9-13,15-16,18H,2-8,14H2,1H3,(H,25,27);5-6,8-10,13-14H,2-4,7,11-12H2,1H3,(H2,22,29)(H,26,30);5-6,8-10,13-14H,2-4,7,11-12H2,1H3,(H,25,30)(H,28,29);3-5,8-9,11,13-14,21H,2,6-7,10,12H2,1H3,(H,24,26) |
| InChIKey | HZCXWPIZPIXNPY-UHFFFAOYSA-N |
| XLogP | 18.08 |
| TPSA | 590.94 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 50 |
| Heavy Atoms | 180 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2465.00 |
| LogP ≤ 5 | 18.08 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 38 |